Skip to main content
OpenTrials
Completed

NCT Number: NCT06293911

Clinical Comparison of a Postbiotic-gel With Placebo Gel for Gingival Inflammation in Patients With Down Syndrome

The aim of the study is to evaluate the efficacy of home treatment with a postbiotic-based gel for the management of periodontal inflammation in patients with Down syndrome.

Patients will be enrolled at the S.C. Odontostomatologia dell'Azienda Ospedaliera "Ordine Mauriziano di Torino", Turin, Italy. After the collection of the periodontal clinical indexes (BoP%, PCR%, dental mobility, mMGI, compliance and satisfaction questionnaire), patients will undergo a professional mechanical debridement with ultrasonic instruments and glycine powders.

Then, they will be randomly divided into two groups according to the home treatment:

* in the Trial group Biorepair Plus Parodontgel Intensive (containing microRepair®, hyaluronic acid, Lactobacillus Ferment and Aloe Barbadensis Leaf Juice Powder) will be used once a day for all the duration of the study * in the Control group, a placebo gel without (active ingredients) will be used once a day for all the duration of the study.

Indexes will be re-evaluated after 1 (T1), 3 (T2) and 6 months. The professional mechanical debridement will be performed again at T3 timepoint.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • not bedridden patients with Down syndrome
  • gingival inflammation and bleeding

Exclusion criteria

  • lack of compliance signalled by caregivers
  • other systemic diseases

Treatment and study plan

Biorepair Plus Parodontgel Intensive

Other

The Biorepair Plus Parodontgel Intensive gel will be used after home oral hygiene once a day.

Placebo gel

Other

The placebo gel (without hyaluronic acid, Lactobacillus Ferment, Aloe Barbadensis Leaf Juice Powder and lactoferrin) will be used after home oral hygiene once a day.

Primary outcomes

  1. Change in Bleeding on Probing (BOP%)

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    Dichotomous scoring (yes/no) of bleeding sites on 4 surfaces of teeth.

  2. Change in Plaque Control Record (PCR%)

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    % assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.

  3. Change in Dental mobility

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    Scoring criteria

    Grade 0: oscillation within 0.2 mm; the teeth move naturally and there are no mobility problems; Grade I: horizontal mobility of the tooth from 0.2 to 1 mm; Grade II: horizontal mobility of the tooth from 1 to 2 mm; Grado III: horizontal mobility equal to or greater than 3 mm or vertical mobility of the tooth.

  4. Change in Modified Gingival Index

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    Scoring criteria (one measurement for each tooth: upper first incisors, first premolars/first primary molars and first molars):

    • Absence of inflammation

    Mild inflammation (marginal or papillary unit) Mild inflammation (entire marginal and papillary unit) Moderate inflammation Severe inflammation

  5. Change in compliance

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    Subjective evaluation of the patient's degree of compliance with the proposed treatment by Visual Analogue Scale (VAS), assessing compliance with dosage, alterations and modifications on lifestyle, and adherence to set recalls; to which is associated a score from 0 to 10 of which:

    • 0 to 2: Poor compliance;
    • 3 to 5: Sufficient compliance;
    • 6 to 8: Good compliance;
    • 9 to 10: Excellent compliance.
  6. Change in product satisfaction

    Time frame: Baseline (T0), after 1 month (T1), 3 months (T2) and after 6 months (T3)

    • Product liking questionnaire: evaluation of taste, smell, consistency, persistence and ease of application by Visual Analogue Scale (VAS) and filling out a questionnaire to which a score from 0 to 10 is associated, of which:
    • 0: Insufficient;
    • 1 to 3: Sufficient;
    • 4 to 6: Good;
    • 7 to 9: Very Good;
    • 10: Excellent.

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Registry information

Official study title

Clinical Comparison of a Postbiotic-gel With Placebo Gel for Gingival Inflammation in Patients With Down Syndrome: Randomized Clinical Trial

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Mar 5, 2024
Registry last updated
Dec 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.